HPGC(SH:600664) Shang Hai Zheng Quan Bao·2025-10-24 18:52Core Viewpoint - The board of directors of Harbin Pharmaceutical Group Co., Ltd. (哈药股份) ensures the authenticity, accuracy, and completeness of the quarterly report, taking legal responsibility for its content [2][8]. Financial Data Summary - The third-quarter financial statements for 2025 have not been audited [3]. - The report includes major accounting data and financial indicators, with specific emphasis on non-recurring gains and losses [4][5]. - The report indicates that there were no significant changes in the financial indicators compared to previous periods [5]. Shareholder Information - The total number of ordinary shareholders and the status of the top ten shareholders are documented, although there are no changes in the lending of shares for the top shareholders [6]. Other Important Information - The board meeting held on October 24, 2025, confirmed that the third-quarter report complies with relevant laws and regulations, accurately reflecting the company's financial status and operational performance [8][10].